Compounds > efavirenz

efavirenz and Psychotic Disorders

efavirenz has been researched along with Psychotic Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Arnaiz, A; Arrúe, A; Basterreche, N; Olivas, O; Zumárraga, M1
Economou, I; Karela, A; Lagadinou, M; Pouliasi, F; Tsigkou, A; Velissaris, D; Zareifopoulos, N1
Boussetta, A; Elloumi, H; Gaha, N; Ghachem, R; Ghazali, I; Zalila, H1
Arendt, G; Haslinger, BA1
Godfried, MH; van Santen, G; van Twillert, G1
Bloemkolk, D; Sierink, HD1
Casteelen, G; Oudijn, MS; Vrijlandt, CM1
Burger, D; Hoffmann, F; Huss, K; Jansson, A; Kurowski, M; Notheis, G; Wintergerst, U1

Reviews

1 review(s) available for efavirenz and Psychotic Disorders

ArticleYear
Efavirenz as a psychotropic drug.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:20

    Topics: Alkynes; Benzoxazines; Cyclopropanes; Humans; Psychotic Disorders; Psychotropic Drugs

2020

Other Studies

7 other study(ies) available for efavirenz and Psychotic Disorders

ArticleYear
Repeat episode of late-onset psychosis associated with efavirenz.
    Actas espanolas de psiquiatria, 2020, Volume: 48, Issue:4

    Topics: Age of Onset; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delusions; HIV Infections; Humans; Male; Middle Aged; Psychotic Disorders

2020
Acute psychosis under efavirenz in a HIV patient.
    La Tunisie medicale, 2010, Volume: 88, Issue:2

    Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Male; Psychotic Disorders; Reverse Transcriptase Inhibitors

2010
[Psychiatric diseases and HIV infection. These patients are dually stigmatized].
    MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1

    Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Diagnosis, Differential; Humans; Oxazines; Patient Compliance; Prejudice; Psychoses, Substance-Induced; Psychotic Disorders

2003
[Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    Nederlands tijdschrift voor geneeskunde, 2005, Nov-26, Volume: 149, Issue:48

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Black People; Cyclopropanes; Female; Ghana; HIV Infections; Humans; Metabolic Clearance Rate; Netherlands; Oxazines; Psychotic Disorders

2005
[Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    Nederlands tijdschrift voor geneeskunde, 2006, Mar-18, Volume: 150, Issue:11

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Black People; Cyclopropanes; Diagnosis, Differential; Emergency Services, Psychiatric; HIV Infections; Humans; Oxazines; Psychotic Disorders

2006
[Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    Nederlands tijdschrift voor geneeskunde, 2006, Mar-18, Volume: 150, Issue:11

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Diagnosis, Differential; Emergency Services, Psychiatric; HIV Infections; Humans; Oxazines; Psychotic Disorders

2006
Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6

    Topics: Adolescent; Age Factors; Alkynes; Anti-HIV Agents; Attention; Benzoxazines; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cyclopropanes; Dyssomnias; HIV Infections; HIV-1; Humans; Metabolic Clearance Rate; Plasma; Psychotic Disorders; Seizures; Treatment Outcome; Treatment Refusal; Viral Load

2008